Mapping IDs Geographic Access Barriers for Diabetic Retinopathy

Share this content:
Mapping IDs Geographic Access Barriers for Diabetic Retinopathy
Mapping IDs Geographic Access Barriers for Diabetic Retinopathy

THURSDAY, May 25, 2017 (HealthDay News) -- Geographic information systems mapping can visualize geographic access barriers to eye care among patients with diabetes, while telescreening can increase the rate of diabetes retinopathy evaluation, according to two studies published online May 18 in JAMA Ophthalmology.

Pooja D. Jani, M.D., from the University of North Carolina at Chapel Hill, and colleagues used geographic information systems mapping techniques to visualize access barriers to eye care for patients with diabetes in a cross-sectional study conducted in five primary care clinics in North Carolina. A total of 1,787 patients with diabetes received retinal screening photographs with remote expert interpretation to identify diabetic retinopathy. The researchers found that the widest distribution of zip codes was seen at the Greenville site. Ophthalmologists were concentrated around urban centers, while primary care physicians were spread across the state.

In a second study, Jani and colleagues examined retinal telescreening for patients with diabetes in a pre- and postimplementation evaluation. Data were included for 1,661 patients at five primary care clinics serving rural and underserved populations in North Carolina. The researchers found that the mean rate of diabetic retinopathy screening was 25.6 percent before implementation of the program, and increased to 40.4 percent after implementation. Within the study period, 60 percent of referred patients completed an ophthalmology referral visit. The odds of requiring a referral were increased for older patients, African-American patients, and other racial/ethnic minorities (odds ratios, 1.28, 1.84, and 2.19).

"Retinal telescreening increased the rate of evaluation for DR for patients in rural and underserved settings," the authors write in the second study.

One author from both studies disclosed financial ties to Welch Allyn.

Abstract/Full Text 1 (subscription or payment may be required)
Abstract/Full Text 2 (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »